Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trial.

Abstract

OBJECTIVES Prognostic and predictive ability of circulating vascular endothelial growth factor (VEGF), stromal derived factor (SDF)-1α and soluble VEGF receptors (sVEGFR) 2 and 3, were evaluated in non-small cell lung cancer (NSCLC) patients enrolled in NCIC Clinical Trials Group BR. 24 comparing chemotherapy with or without cediranib. MATERIALS AND… (More)
DOI: 10.1016/j.lungcan.2015.09.004

Topics

Cite this paper

@article{Addison2015AnalysisOS, title={Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trial.}, author={Christina L Addison and Keyue Ding and Lesley K Seymour and Huijun Zhao and Scott A. Laurie and Frances A. Shepherd and Glenwood D Goss and Penelope Ann Bradbury}, journal={Lung cancer}, year={2015}, volume={90 2}, pages={288-95} }